Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹10.0 LAccepted-Finance | ₹10.0 L | L1 | Accepted-Finance L1 BIDDER |
| 2 | L2₹10.7 L+₹66,038.40 (6.58%)Accepted-Finance | ₹10.7 L+₹66,038.40 (6.58%) | L2 | Accepted-Finance NOT L1 BIDDER |
| 3 | L3₹11.2 L+₹1.2 L (12.0%)Accepted-Finance | ₹11.2 L+₹1.2 L (12.0%) | L3 | Accepted-Finance NOT L1 BIDDER |
| 4 | Rejected-Technical SHOP NO 110A PRESTIGE POINT PREMISES CO OPERATIVE SOCIETY 283 SHUKRAWAR PETH PUNE PUNE MAHARASHTRA 411002 | PUNE | MAHARASHTRA | 411002 | - | - | Rejected-Technical Not Accepted due to unable authorization letter of OEM |
Tender Value
₹10.2 L
EMD Value
₹30,482
Closing Date
16 Mar 2022, 6:00 pmClosed
Col Nithin Bajaj
AICTS,PUNE-411040
CATEGORY I (Drugs/ Vaccines Consumables)
2022_ARMY_512936_1
630/MS/DGLP/ECHS/OTE/259/21-22
Open Tender
Miscellaneous Goods
Supply
30 days
AICTS PUNE
Please refer Tender documents.
3 documents required · 3 mandatory
₹0
₹30,482
29 Mar 2022
10 Mar 2022
17 Mar 2022
10 Mar 2022
16 Mar 2022
10 Mar 2022
10 Mar 2022 - 14 Mar 2022
Medicals Items :
Synchrobreathe inhaler with Salmeterol 25 mcg and Fluticasone propionate 250 mcg (120 doses)
Synchrobreathe inhaler with Salmeterol 25 mcg and Fluticsone propionate 125 mcg (120 doses)
Synchrobreathe inhaler with Formoterol 6 mcg and Budesonide 200 mcg
Synchrobreathe inhaler with Formoterol 6 mcg and Budesonide 400 mcg
Jainam Pharma (I) Pvt. Ltd.
Shreekrishna Distributors
stage.html
html • 0.04 MB
tech_bid_open.pdf
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
fin_eval.pdf
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .